BrainScan

BrainScan LT Debt/Equity

Long-Term Debt to Equity Ratio of BrainScan (BSN.WA) as of Oct 19, 2026.

LT Debt/Equity

0.00

Last updated:

Long-Term Debt to Equity Ratio of BrainScan is 2025 0.00 . Long-Term Debt to Equity Ratio of BrainScan was 2024 0.00 . It decreases by % lower compared to the previous year.

The BrainScan LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2022
0.00 PLN
Jan 1, 2023
0.00 PLN
Jan 1, 2024
0.00 PLN
Jan 1, 2025
0.00 PLN
The BrainScan LT Debt/Equity history
YEARLT Debt/EquityYoY
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BrainScan Stock analysis

What does BrainScan do? BrainScan SA, headquartered in Gdańsk, Poland, operates in the health care sector, specializing in AI-driven brain imaging diagnostics. The company's flagship BrainScan CT system delivers head tomography analysis in under three minutes, identifying tumors, hemorrhages, and other abnormalities through deep learning. It optimizes diagnostic workflows and enables rapid patient triage, significantly accelerating treatment decisions. Listed on May 15, 2024, the company serves medical facilities across Poland. BrainScan is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrainScan stock

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio BrainScan since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's BrainScan with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — BrainScan

All Key Metrics — BrainScan